Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation

Basit Öğe Kaydı
dc.authoridAnmar Al-Taie / 0000-0002-2183-6830en_US
dc.authorscopusidAnmar Al-Taie / 57221579036
dc.authorwosidAnmar Al-Taie / I-8549-2019en_US
dc.date.accessioned2022-06-17T09:15:46Z
dc.date.available2022-06-17T09:15:46Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Ana Bilim Dalıen_US
dc.description.abstractBackground: The aim of this study was to provide a scoping and comprehensive review for the clinical outcomes from the cross-link of Type 2 diabetes mellitus (T2DM), COVID-19, and sarcopenia. Methods: By using PRISMA guidelines and searching through different databases that could provide findings of evidence on the association of T2DM, COVID-19, and sarcopenia. Results: Thirty-three studies reported a relationship between sarcopenia with T2DM, twenty-one studies reported the prognosis COVID-19 in patients with T2DM, ten studies reported the prognosis of COVID-19 in patients with sarcopenia, five studies discussed the outcomes of sarcopenia in patients with COVID-19, and one study reported sarcopenia outcomes in the presence of T2DM and COVID-19. Conclusion: There is an obvious multidimensional relationship between T2DM, COVID-19 and sarcopenia which can cause prejudicial effects, poor prognosis, prolonged hospitalisation, lowered quality of life and a higher mortality rate during the current COVID-19 pandemic.en_US
dc.identifier.citationAl-Taie A, Arueyingho O, Khoshnaw J, Hafeez A. Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation. Arch Physiol Biochem. 2022 Jun 15:1-19. doi: 10.1080/13813455.2022.2086265. Epub ahead of print. PMID: 35704400.en_US
dc.identifier.doi10.1080/13813455.2022.2086265en_US
dc.identifier.issn1381-3455en_US
dc.identifier.pmid35704400en_US
dc.identifier.scopus2-s2.0-85131939470en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttp://doi.org/10.1080/13813455.2022.2086265
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2920
dc.identifier.wosWOS:000811660600001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorAl-Taie, Anmar
dc.language.isoenen_US
dc.publisherTaylor and Francisen_US
dc.relation.ispartofArchives of Physiology and Biochemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectMuscle Massen_US
dc.subjectSARS-CoV-2en_US
dc.subjectSarcopeniaen_US
dc.subjectType 2 Diabetes Mellitusen_US
dc.titleClinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluationen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
Ä°sim:
Clinical outcomes of multidimensional association of type 2 diabetes mellitus COVID 19 and sarcopenia an algorithm and scoping syste.pdf
Boyut:
2.24 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Ä°ndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
Ä°sim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
Ä°ndir

Koleksiyon

PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu